The price of Spravato (esketamine nasal spray) varies depending on factors such as insurance coverage, pharmacy, and location [1]. For individuals with commercial insurance, out-of-pocket costs can be reduced through the Janssen CarePath Savings Program, which may offer eligible patients as low as a $0 co-pay for a month's supply [1]. However, there are program limits and restrictions [1].
How much does Spravato cost without insurance?
Without insurance, the cost of Spravato can be significantly higher. A single unit of Spravato, which typically contains two nasal spray devices, can cost several hundred dollars [2]. For instance, one prescription may cost upwards of $800, with some sources indicating prices around $888 for a single nasal spray prescription [3].
What insurance plans cover Spravato?
Spravato is covered by many insurance plans, but coverage can differ. The Janssen CarePath program can help determine if a patient's specific insurance plan provides coverage and what their out-of-pocket expenses might be [1]. Patients are advised to contact their insurance provider directly for detailed information on their plan's benefits for Spravato [1].
Are there patient assistance programs for Spravato?
Yes, the Janssen CarePath Savings Program is available for eligible patients with commercial prescription insurance [1]. This program aims to lower out-of-pocket costs, potentially reducing the co-pay to $0 for a month's supply [1]. Eligibility requirements and program limitations apply, and patients should consult the program details for specifics [1].
How does Spravato's price compare to other depression treatments?
Comparing the price of Spravato to other depression treatments involves looking at a range of options. Traditional oral antidepressants, such as SSRIs and SNRIs, are generally less expensive, especially when available as generics [4]. However, these treatments may not be effective for individuals with treatment-resistant depression, for whom Spravato is indicated [5]. The cost of Spravato should be considered in the context of its specific indication and potential efficacy for patients who have not responded to other therapies.
When does Spravato's patent expire?
The patent landscape for Spravato is complex and involves multiple patents. According to DrugPatentWatch.com, there are several patents related to Spravato, with expiry dates extending into the future [6]. These patents cover aspects of the drug itself and its methods of use [6]. Understanding the exact patent expiry is crucial for potential generic or biosimilar competition, though specific dates can be subject to legal challenges and extensions [6].
What are the approved uses for Spravato?
Spravato is approved for the treatment of depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions [5]. It is also approved for depressive symptoms in adults with MDD that is inadequately treated by standard antidepressant therapies (treatment-resistant depression) [5].
Sources:
[1] https://www.janssencarepath.com/patient/spravato/savings-and-support
[2] https://www.goodrx.com/spravato
[3] https://www.singlecare.com/prescription/spravato
[4] https://www.medicalnewstoday.com/articles/326148
[5] https://www.spravato.com/
[6] https://www.drugpatentwatch.com/p/us/esketamine